Business
Orthofix Expands Pediatric Limb Reconstruction Portfolio with New FITBONE™ Innovation at POSNA 2026 Annual Meeting
LEWISVILLE, Texas, May 06, 2026--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced new pediatric limb reconstruction innovations that expand treatment options for pediatric and small stature patients. The Company will highlight these advances at the Pediatric Orthopedic Society of North America (POSNA) 2026 Annual Meeting, which takes place May 6-8, 2026, at the Rosen Shingle Creek Hotel in Orlando, Florida.
About this update from Orthofix Medical Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1528,"height":235,"url":"https://media.zenfs.com/en/business-wire.com/bd74c1cfc704fd79400887b93eadc37a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Ub0cuPwo1pT_0jt3BfxkvQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE0OA--/https://media.zenfs.com/en/business-wire.com/bd74c1cfc704fd79400887b93eadc37a","width":960,"height":148},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/70NqE2KrDbN_sFgPf8dWMA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zNzA-/https://media.zenfs.com/en/business-wire.com/bd74c1cfc704fd79400887b93eadc37a","width":1200,"height":185}},"lazy":false},{"type":"text","content":"LEWISVILLE, Texas, May 06, 2026--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced new pediatric limb reconstruction innovations that expand treatment options for pediatric and small stature patients. The Company will highlight these advances at the Pediatric Orthopedic Society of North America (POSNA) 2026 Annual Meeting, which takes place May 6-8, 2026, at the Rosen Shingle Creek Hotel in Orlando, Florida.","length":476,"tagName":"p"},{"type":"text","content":"At POSNA 2026, Orthofix will showcase its comprehensive pediatric limb reconstruction portfolio at exhibit booth #34, including the recently launched FITBONE Trochanteric Intramedullary Lengthening System and new enhancements to its OrthoNext™ planning software platform.","length":271,"tagName":"p"},{"type":"text","content":""Building on the success of our FITBONE limb-lengthening portfolio, the introduction of the FITBONE Trochanteric system marks an important milestone for Orthofix and the surgeons and patients we serve," said Patrick Fisher, President, Global Biologics and Limb Reconstruction. "This innovation enables surgeons to treat a broader spectrum of patients, including pediatric and small stature individuals who may require an alternate entry approach. In addition, the latest OrthoNext 2.1 planning software enhancements underscore our focus on delivering integrated digital and surgical tools that simplify deformity analysis and streamline correction planning for fixation procedures."","length":702,"tagName":"p"},{"type":"text","content":"At the meeting, Orthofix will...